- The 3rd Annual Conference on Brain Metastases was held virtually August 19–20, 2021.
- Nir Lipsman, MD, PhD, presented data from his recently completed metastatic breast cancer treatment study.
- The meeting included live presentations, prerecorded abstract presentations, and an electronic poster session.
On August 19 and 20, 2021, the Society for Neuro-Oncology (SNO) hosted its 3rd Annual Conference on Brain Metastases, as a virtual gathering. The meeting included live presentations, prerecorded abstract presentations, and an electronic poster session.
“It was exciting to have focused ultrasound clinical trial data featured at this multidisciplinary brain metastases meeting,” said Suzanne LeBlang, MD, the Foundation’s Director of Clinical Relationships. “Dr. Nir Lipsman, from Sunnybrook Health Sciences Centre, provided a preview of the data from his clinical trial using focused ultrasound to enhance the effectiveness of chemotherapy drugs in patients with HER2+ breast cancer metastases to the brain.”
Session 1 included three presentations that may be of interest to the focused ultrasound community:
- Brain Metastasis of Breast Cancer by Patricia Steeg, PhD*
- Brain Metastasis: From a Cancer Neuroscience Perspective by Josh Neman, PhD
- Keynote: Evolving Role of Immunotherapy for Brain Metastases, Kim Margolin, MD
Session 4 included a presentation by Kristin Redmond, MD, MPH, on the Synergy of Radiotherapy and Immunotherapy for Brain Metastases.
Session 7 covered imaging biomarkers with three excellent presentations.
Session 8 featured neurosurgical innovations in the management of brain metastases. Nir Lipsman, MD, PhD, presented “Focused Ultrasound for Brain Metastases,” to preview data from his metastatic breast cancer clinical trial.
See the Meeting Program >
*Dr. Steeg has also published a comprehensive review of blood-tumor barrier structure and function in Nature Reviews Clinical Oncology. See The Blood-Tumor Barrier in Cancer Biology and Therapy.